1. Home
  2. AXDX

AXDX

Accelerate Diagnostics Inc.

Logo Accelerate Diagnostics Inc.

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Founded: 1982 Country:
United States
United States
Employees: N/A City: TUCSON
Market Cap: 18.1M IPO Year: 1996
Target Price: $1.00 AVG Volume (30 days): 135.9K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.94 EPS Growth: N/A
52 Week Low/High: $0.83 - $11.90 Next Earning Date: 05-09-2024
Revenue: $12,059,000 Revenue Growth: -5.43%
Revenue Growth (this year): 3.19% Revenue Growth (next year): 18.69%

Share on Social Networks: